- Overview
-
My research focuses on improving the understanding of how chromosomal abnormalities result in an abnormal phenotype (e.g., cancer, malformations, or intellectual disability). I am also interested in the applications of genomics to the area of clinical diagnosis.
- Research
-
Grants
2011/9-2016/9 Rare Obesity Disorders Informing Common Disease, CIHR Operating Grant; Co-investigator (PI: William Gibson)
2010/9-2011/9 Rare Obesity Disorders Informing Common Disease, CIHR Operating Grant INMD Start-up Funds; Co-investigator (PI: William Gibson)
Research Group MembersDavid Chai, Clinical Laboratory Technologist
Kathryn Hepburn, Cytogenetics Technologist
Duda Markovic, Lab Assistant
Wing Mung, Cytogenetics Technologist
Cutting-edge genomic technology to help improve medication safety for children in new BC Children’s led study
Dr. Bruce Carleton will be leading a new $17 million project to make medications safer for children across Canada. By uncovering the genetic variations in patients that can lead to adverse drug reactions, this research could help explain differing medication responses and improve disease outcomes.
